Introduction/Overview The pharmacological modulation of cardiac contractility represents a cornerstone in the management of heart failure and certain arrhythmias. Agents that increase the force of myocardial contraction, known as positive inotropes, have been utilized for centuries, with cardiac glycosides holding a particularly storied position in medical history. Despite the evolution of heart failure management towards … Read more
Introduction/Overview Antiarrhythmic drugs constitute a critical therapeutic class designed to suppress or prevent abnormal cardiac rhythms, known as arrhythmias. These disorders of cardiac impulse formation or conduction can range from benign palpitations to life-threatening ventricular tachyarrhythmias, contributing significantly to global cardiovascular morbidity and mortality. The fundamental goal of antiarrhythmic pharmacotherapy is to restore and maintain … Read more
Introduction/Overview Cardiac arrhythmias represent a diverse group of disorders characterized by abnormal electrical activity in the heart, leading to disturbances in rate, rhythm, or sequence of cardiac depolarization. The pharmacological management of these conditions constitutes a critical component of cardiovascular therapeutics. Antiarrhythmic drugs are employed to suppress or prevent arrhythmias, thereby alleviating symptoms, improving hemodynamic … Read more
1. Introduction/Overview Hypertension represents a major modifiable risk factor for cardiovascular, cerebrovascular, and renal diseases, contributing significantly to global morbidity and mortality. The pharmacological management of elevated blood pressure is a cornerstone of preventive cardiology and internal medicine. Antihypertensive pharmacotherapy aims to reduce the long-term complications associated with sustained high blood pressure, including stroke, myocardial … Read more
1. Introduction/Overview Hypertension represents a major global public health challenge, constituting a primary modifiable risk factor for cardiovascular disease, stroke, renal failure, and mortality. The pharmacological management of elevated blood pressure is a cornerstone of preventive cardiology and internal medicine. Antihypertensive pharmacotherapy aims to reduce long-term morbidity and mortality by achieving and maintaining blood pressure … Read more
1. Introduction/Overview Myocardial infarction (MI), commonly known as a heart attack, represents a critical medical emergency characterized by the irreversible necrosis of cardiac myocytes secondary to prolonged ischemia. This event is most frequently precipitated by the acute thrombotic occlusion of a coronary artery, typically arising from the rupture or erosion of an atherosclerotic plaque. The … Read more
1. Introduction/Overview The pharmacological induction of vasodilation represents a cornerstone therapeutic strategy in the management of numerous cardiovascular and non-cardiovascular disorders. Vasodilators are a heterogeneous group of agents that act through diverse mechanisms to reduce vascular smooth muscle tone, leading to an increase in the caliber of blood vessels. This reduction in peripheral vascular resistance, … Read more
Introduction/Overview Beta-adrenergic receptor antagonists, commonly termed beta blockers, constitute a cornerstone of pharmacotherapy for a spectrum of cardiovascular disorders. These agents competitively inhibit the binding of endogenous catecholamines—epinephrine and norepinephrine—to beta-adrenergic receptors, thereby attenuating sympathetic nervous system activity. The clinical introduction of propranolol in the 1960s marked a pivotal advancement in cardiovascular medicine, fundamentally altering … Read more
1. Introduction/Overview Calcium channel blockers (CCBs) represent a major class of cardiovascular drugs that inhibit the transmembrane influx of calcium ions through voltage-gated L-type calcium channels. The therapeutic utility of these agents is predicated on their ability to modulate calcium-dependent physiological processes, particularly within the cardiovascular system. Since their introduction in the 1960s, CCBs have … Read more
Introduction/Overview The renin-angiotensin-aldosterone system (RAAS) represents a critical hormonal cascade in the regulation of blood pressure, fluid balance, and cardiovascular homeostasis. Pharmacological antagonism of this system constitutes a cornerstone in the management of hypertension, heart failure, and chronic kidney disease. Angiotensin receptor blockers, also known as angiotensin II receptor antagonists or AT1 receptor blockers, are … Read more